Market Trends of Argentina Respiratory Devices Industry
Inhalers in Therapeutic Devices are Estimated to Witness Healthy Growth in the Future
The therapeutic devices segment is expected to experience robust growth during the forecast period due to the increasing prevalence of respiratory disorders, a growing patient population with chronic diseases, and a rising geriatric population.
Therapeutic devices such as inhalers are essential for managing respiratory disorders. The availability of reimbursement coverage and the rising number of asthma patients in Argentina support market growth.
According to a study published in the Official Journal of the Asian Pacific Society of Respirology in November 2023, severe asthma (SA) in Argentina was estimated to affect over 1.6 million individuals. Notably, 31% of patients attending specialized asthma centers were diagnosed with asthma according to the ATS/ERS guidelines, with a significant 64.1% failing to achieve adequate disease control. Therefore, such a huge prevalence of chronic respiratory conditions such as asthma is anticipated to increase the adoption of respiratory therapeutic devices such as inhalers, boosting the segment’s growth.
Thus, the increasing efficacy and tolerability of monoclonal antibody drugs, rising product approvals, and research and development activities by market players are expected to drive the growth of this segment over the forecast period.
Sleep Test Devices in Diagnostic and Monitoring Devices are Anticipated to Record Significant Growth Over the Forecast Period
Sleep test devices, also known as sleep monitors or trackers, are essential for diagnosing and monitoring sleep disorders such as sleep apnea and insomnia. These devices range from simple wearable trackers to sophisticated medical-grade equipment used in sleep studies.
The high prevalence of sleep disorders in the country is anticipated to increase the adoption of sleep devices, boosting the segment’s growth. For instance, according to the study published in the Journal of Allergy and Clinical Immunology in February 2024, intermediate and high-risk obstructive sleep apnea (OSA) accounted for 54% of cases, while insomnia followed closely at 33% in Argentina. Therefore, the high prevalence of OSA is anticipated to increase the number of sleep monitoring devices such as CPAP machines, thereby boosting segmental growth.
Furthermore, according to a study published by Universidad Favaloro in March 2023, 75% of the population in Argentina had some type of sleep disorder. Therefore, the high prevalence of sleep disorders in the country is anticipated to increase the adoption of sleep testing devices for the detection of quality sleep in patients, thereby boosting the segment's growth.
Thus, the rising number of sleep disorders such as obstructive sleep apnea and insomnia is anticipated to increase the demand for sleep testing devices in the country, thereby boosting the segment's growth.
